NO911449L - Fremgangsmaate for fremstilling av et farmasoeytisk preparat - Google Patents

Fremgangsmaate for fremstilling av et farmasoeytisk preparat

Info

Publication number
NO911449L
NO911449L NO91911449A NO911449A NO911449L NO 911449 L NO911449 L NO 911449L NO 91911449 A NO91911449 A NO 91911449A NO 911449 A NO911449 A NO 911449A NO 911449 L NO911449 L NO 911449L
Authority
NO
Norway
Prior art keywords
hydrogen
preparing
alkyl
procedure
pharmaceutical preparation
Prior art date
Application number
NO91911449A
Other languages
English (en)
Norwegian (no)
Other versions
NO911449D0 (no
Inventor
Leif Helth Jensen
Joergen Drejer
Frank Waetjen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of NO911449D0 publication Critical patent/NO911449D0/no
Publication of NO911449L publication Critical patent/NO911449L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Fats And Perfumes (AREA)
NO91911449A 1990-04-13 1991-04-12 Fremgangsmaate for fremstilling av et farmasoeytisk preparat NO911449L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50928490A 1990-04-13 1990-04-13

Publications (2)

Publication Number Publication Date
NO911449D0 NO911449D0 (no) 1991-04-12
NO911449L true NO911449L (no) 1991-10-14

Family

ID=24026006

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91911449A NO911449L (no) 1990-04-13 1991-04-12 Fremgangsmaate for fremstilling av et farmasoeytisk preparat

Country Status (12)

Country Link
EP (1) EP0451626B1 (ja)
JP (1) JP3015129B2 (ja)
AT (1) ATE157873T1 (ja)
CA (1) CA2040242A1 (ja)
DE (1) DE69127572T2 (ja)
DK (1) DK0451626T3 (ja)
ES (1) ES2108017T3 (ja)
FI (1) FI911784L (ja)
GR (1) GR3025186T3 (ja)
IE (1) IE910939A1 (ja)
NO (1) NO911449L (ja)
PT (1) PT97365B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5317018A (en) * 1992-06-09 1994-05-31 Armin Walser Benzodiazepines and compositions for treating anxiety and panic disorders, and idiopathic and psychomotor epilepsy
EP1367056A1 (en) * 1992-07-24 2003-12-03 The Regents Of The University Of California Drugs that enhance synaptic responses mediated by AMPA receptors
US5852008A (en) * 1995-01-24 1998-12-22 The Regents Of The University Of California Heteroatom substituted benzoyl derivatives that enhance synaptic response mediated by receptors
DE19604919A1 (de) * 1996-02-01 1997-08-07 Schering Ag Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
GB2316616A (en) * 1996-09-02 1998-03-04 Lilly Industries Ltd Modulation of GluR5 receptors in the hippocampus to treat psychiatric disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC1528A1 (fr) * 1982-07-21 1984-04-13 Hoffmann La Roche Imidazobenzodiazepines
CA1327008C (en) * 1988-01-15 1994-02-15 Walter Merz Anti-psychotic imidazobenzodiazepine

Also Published As

Publication number Publication date
NO911449D0 (no) 1991-04-12
DE69127572T2 (de) 1998-01-22
EP0451626A3 (en) 1992-10-07
DK0451626T3 (da) 1998-04-20
FI911784A7 (fi) 1991-10-14
IE910939A1 (en) 1991-10-23
FI911784A0 (fi) 1991-04-12
ES2108017T3 (es) 1997-12-16
ATE157873T1 (de) 1997-09-15
PT97365A (pt) 1992-01-31
CA2040242A1 (en) 1991-10-14
EP0451626A2 (en) 1991-10-16
EP0451626B1 (en) 1997-09-10
FI911784L (fi) 1991-10-14
PT97365B (pt) 1998-08-31
DE69127572D1 (de) 1997-10-16
JPH04224516A (ja) 1992-08-13
GR3025186T3 (en) 1998-02-27
JP3015129B2 (ja) 2000-03-06

Similar Documents

Publication Publication Date Title
NO903851D0 (no) Fremgangsmaate for fremstilling av n-substituerte-4-pyrimidinaminer og -pyrimidindiaminer, og deres anvendelse som medikamenter.
NO913750L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
EA200000592A1 (ru) Азаполициклические соединения, конденсированные с арилом
FI941378A0 (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
PT723538E (pt) Compostos triciclicos de carbamato uteis para a ainibicao da funcao da proteina g e para o tratamento de doencas proliferativas
NO174549C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, asymmetrisk substituerte, heterocykliske forbindelser
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
FI94354C (fi) Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi
NO882239L (no) Fremgangsmaate for fremstilling av terapeutisk aktive cykliske peptider.
NO911449D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
ATE92315T1 (de) Aminosaeurederivate enthaltende antikonvulsive zusammensetzungen und verwendung dieser aminosaeurederivate.
NO173991C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
CY1105550T1 (el) Μεμνο-πεπτιδια, μια διαδικασια για την παρασκευη και τη χρηση τους
NO861868L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatian-derivater.
IL104657A0 (en) Benzazepine derivatives,their preparation and pharmaceutical compositions containing them
IT1241927B (it) 3'-deamino-4'-deossi-4'-amino-8-fluoroantra- cicline processi per la loro preparazione e composizioni farmaceutiche che le contengono
ATE283269T1 (de) 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
DE69327077D1 (de) Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
DK0419844T3 (da) N-Hydroxy-dibenz(b,e)oxepin-alkylaminer og -alkansyreamider, beslægtede heterocycliske analoger, fre mgangsmåde til deres fremstilling og deres anvendelse ved fremstilling af lægemidler
ATE95697T1 (de) Uricosuretische zusammensetzung.